SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Advancing the sensori-/psychomotor domain in schizophrenia spectrum disorders: From clinical observation to translational innovation.

Schizophr Res · 2025-09-29

DOI: 10.1016/j.schres.2025.09.021PMID: 41027081

Check source for accessResearch Support, Non-U.S. Gov't; Review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Sensori-/psychomotor dysfunction has historically been an underrecognized domain in schizophrenia spectrum disorders (SSD), often overshadowed by a narrow focus on medication-induced side effects such as acute extrapyramidal motor symptoms, akathisia, dystonia, parkinsonism, and tardive dyskinesia. Two decades ago, research in this area was largely confined to these pharmacologically related phenomena, as well as to neurological soft signs (NSS) and catatonia. In the last ten years, however, the sensori-/psychomotor domain has garnered renewed interest as a core feature of SSD-relevant not only for symptom profiling but also for early detection, prognostic stratification, and individualized treatment planning across the lifespan. This narrative review synthesizes major advances from the past five years across Psychiatry, Neuroscience, Human Movement Science, and Affective Computing. It highlights a paradigm shift from traditional hand-based sensori-/psychomotor assessments toward novel, scalable approaches for investigating sensori-/psychomotor dysfunction. Emerging tools-such as actigraphy, 3D motion capture systems, standardized sensorimotor tasks, and multimodal neuroimaging-now allow for more objective, multimodal assessment of sensori-/psychomotor behavior, including gesture dynamics and patterns of physical inactivity. In parallel, computational innovations have enabled the large-scale analysis of sensori-/psychomotor abnormalities, including retrospective mining of unstructured clinical notes through natural language processing and machine learning techniques. Together, these developments underscore the shifting view of sensori-/psychomotor dysfunction as more than behavioral epiphenomena or drug effects. We argue that the integration of emerging technologies and refined methodologies into clinical workflows is essential for translating research findings into personalized, real-world care of mental disorders across the lifespan.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.